We specialize in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions

Since launching as a spin-out from the University of Oxford, we have developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.

Global Presence

Clinically Validated Impact on Life-Saving Treatments

30+ countries

56+ Clinical Publications

A patient scanned every 3 minutes

Results available within 1 minute

Local Support

Dedicated Specialist

20+ Languages

Exceptional Training

User Adoption

World-Class Expertise

Our expert team of clinicians, stroke neurologists, scientists, business professionals and engineers have the necessary insight and experience to confidently serve the world’s most demanding clinical communities.

Our Team

Our Mission & Values

At Brainomix, our success is fueled by our world-class team. Knowing that we are making a difference for patients by improving the way clinicians can deliver best-in-class care is felt collectively across the company, providing daily motivation and renewed focus.

Investors

Brainomix is a private company backed by leading healthtech investors, including Boehringer Ingelheim Venture Fund, Parkwalk, and Hostplus via the IP Group Hostplus Innovation Fund.